Lerdelimumab
Product Specifications
CAS Number
285985-06-0
Target
TGF-beta/Smad
Related Pathways
Stem Cells
Bioactivity
Lerdelimumab (CAT-152) is a recombinant human monoclonal antibody of the IgG4 subclass targeting TGF-β2. It holds potential as an anti-scarring agent in glaucoma research [1] [2].
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
